$OPGN
OPGEN INC Stock $opgn

$opgn Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000182912624007586 Filed on November 15, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q3
Revenue			$699.0K
YoY Change			55.78%
Cost Of Revenue			$618.8K
YoY Change			-67.19%
Gross Profit			$80.23K
YoY Change			-105.58%
Gross Profit Margin			11.48%
Selling, General & Admin		$783.4K	$2.371M
YoY Change		-66.96%	-22.32%
% of Gross Profit			2955.17%
Research & Development		$488.00	$1.202M
YoY Change		-99.96%	-40.83%
% of Gross Profit			1498.1%
Depreciation & Amortization			$350.6K
YoY Change			6.46%
% of Gross Profit			436.99%
Operating Expenses		$783.9K	$3.573M
YoY Change		-78.06%	-29.71%
Operating Profit		-$783.9K	-$3.566M
YoY Change		-78.02%	-73.61%
Interest Expense		$3.238K	$396.8K
YoY Change		-99.18%	-30.31%
% of Operating Profit
Other Income/Expense, Net		$9.715M	-$497.3K
YoY Change		-2053.42%	-15.8%
Pretax Income		$8.931M	-$4.063M
YoY Change		-319.82%	-71.19%
Income Tax
% Of Pretax Income
Net Earnings		$8.931M	-$4.063M
YoY Change		-319.82%	-71.19%
Net Earnings / Revenue			-581.23%
Basic Earnings Per Share		$1.43	-$0.46
Diluted Earnings Per Share		$1.35	-$0.46
COMMON SHARES
Basic Shares Outstanding	10.07M shares	1.349M shares	8.900M shares
Diluted Shares Outstanding		6.604M shares	8.778M shares

Balance Sheet

Concept	2024 Q3	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$292.6K
YoY Change		-97.15%
Cash & Equivalents	$1.633M	$292.6K
Short-Term Investments
Other Short-Term Assets		$1.541M
YoY Change		-8.2%
Inventory		$2.807M
Prepaid Expenses
Receivables	$24.40K	$422.7K
Other Receivables		$0.00
Total Short-Term Assets	$3.217M	$3.455M
YoY Change	-6.87%	-74.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.117M	$3.821M
YoY Change	-70.76%	25.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$302.3K	$492.0K
YoY Change	-38.57%	17.29%
Total Long-Term Assets	$2.252M	$14.68M
YoY Change	-84.66%	-24.98%
TOTAL ASSETS
Total Short-Term Assets	$3.217M	$3.455M
Total Long-Term Assets	$2.252M	$14.68M
Total Assets	$5.470M	$18.13M
YoY Change	-69.84%	-44.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$103.9K	$904.6K
YoY Change	-88.52%	32.52%
Accrued Expenses	$89.17K	$1.269M
YoY Change	-92.97%	21.19%
Deferred Revenue		$194.7K
YoY Change
Short-Term Debt		$0.00
YoY Change		-100.0%
Long-Term Debt Due		$9.200M
YoY Change		10.27%
Total Short-Term Liabilities	$589.8K	$12.47M
YoY Change	-95.27%	3.83%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities		$121.4K
YoY Change		-0.06%
Total Long-Term Liabilities		$121.4K
YoY Change		-0.06%
TOTAL LIABILITIES
Total Short-Term Liabilities	$589.8K	$12.47M
Total Long-Term Liabilities		$121.4K
Total Liabilities	$2.484M	$15.46M
YoY Change	-83.93%	-18.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$297.9M	-$288.5M
YoY Change	3.26%	9.97%
Common Stock	$100.7K	$100.1K
YoY Change	0.55%	-79.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.986M	$2.677M
YoY Change
Total Liabilities & Shareholders Equity	$5.470M	$18.13M
YoY Change	-69.84%	-44.98%

Cashflow Statement

Concept	2024 Q3	2023 Q3
OPERATING ACTIVITIES
Net Income	$8.931M	-$4.063M
YoY Change	-319.82%	-71.19%
Depreciation, Depletion And Amortization		$350.6K
YoY Change		6.46%
Cash From Operating Activities		-$2.923M
YoY Change		-38.51%
INVESTING ACTIVITIES
Capital Expenditures		$99.50K
YoY Change		-196.6%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$99.50K
YoY Change		-3.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		25.63K
YoY Change		-102.85%
NET CHANGE
Cash From Operating Activities		-2.923M
Cash From Investing Activities		-99.50K
Cash From Financing Activities		25.63K
Net Change In Cash		-2.997M
YoY Change		-47.94%
FREE CASH FLOW
Cash From Operating Activities		-$2.923M
Capital Expenditures		$99.50K
Free Cash Flow		-$3.023M
YoY Change		-35.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity File Number EntityFileNumber	001-37367
	dei	Entity Registrant Name EntityRegistrantName	OPGEN, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	06-1614015
	dei	Entity Address Address Line1 EntityAddressAddressLine1	23219 Stringtown Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
	dei	Entity Address City Or Town EntityAddressCityOrTown	Clarksburg
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20871
	dei	City Area Code CityAreaCode	240
	dei	Local Phone Number LocalPhoneNumber	813-1260
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	OPGN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6883588	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	336184	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	168819	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001293818
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1151823	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	103316	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	324735	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1579874	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q4	opgn	Eib Loan Guaranty EibLoanGuaranty	10873867	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	147943	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11422242	usd
CY2023Q4	us-gaap	Assets Assets	1882274	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	111149	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	135476	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	463	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-497332	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	11719206	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8931078	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4062957	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7642696	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	8931078	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4062957	usd
	us-gaap	Net Income Loss NetIncomeLoss	7642696	usd
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q4	opgn	Indemnification Assets IndemnificationAssets		usd
CY2024Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2024Q3	opgn	Eib Loan Guaranty EibLoanGuaranty		usd
CY2023Q4	opgn	Shortterm Insurance Financing ShorttermInsuranceFinancing		usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2024Q3	us-gaap	Revenues Revenues		usd
CY2024Q3	opgn	Cost Of Products Sold CostOfProductsSold		usd
CY2024Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating		usd
CY2024Q3	opgn	Gain On Impairment Adjustment GainOnImpairmentAdjustment		usd
CY2023Q3	opgn	Gain On Impairment Adjustment GainOnImpairmentAdjustment		usd
	opgn	Gain On Impairment Adjustment GainOnImpairmentAdjustment		usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	opgn	Gain On Settlement Of Compensation Expenses GainOnSettlementOfCompensationExpenses		usd
	opgn	Gain On Settlement Of Compensation Expenses GainOnSettlementOfCompensationExpenses		usd
CY2024Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss		usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss		usd
CY2023Q3	opgn	Change In Fair Value Of Eib Loan Guaranty ChangeInFairValueOfEibLoanGuaranty		usd
	opgn	Change In Fair Value Of Eib Loan Guaranty ChangeInFairValueOfEibLoanGuaranty		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	opgn	Net Income Loss Allocated To Preferred Stockholders Basic NetIncomeLossAllocatedToPreferredStockholdersBasic		usd
	opgn	Net Income Loss Allocated To Preferred Stockholders Basic NetIncomeLossAllocatedToPreferredStockholdersBasic		usd
CY2024Q3	opgn	Net Income Loss Allocated To Preferred Stockholders NetIncomeLossAllocatedToPreferredStockholders		usd
CY2023Q3	opgn	Net Income Loss Allocated To Preferred Stockholders NetIncomeLossAllocatedToPreferredStockholders		usd
	opgn	Net Income Loss Allocated To Preferred Stockholders NetIncomeLossAllocatedToPreferredStockholders		usd
	opgn	Net Income Loss Allocated To Preferred Stockholders NetIncomeLossAllocatedToPreferredStockholders		usd
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent		usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2023Q1	opgn	Stock Issued During Period Share Cancellation Value StockIssuedDuringPeriodShareCancellationValue		usd
CY2023Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2024Q1	opgn	Reclassification Of Preferred Stock Par Value To Additional Paidin Capital ReclassificationOfPreferredStockParValueToAdditionalPaidinCapital		usd
CY2024Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2024Q2	opgn	Share Issuance Related To Reverse Stock Split ShareIssuanceRelatedToReverseStockSplit		usd
CY2024Q2	opgn	Share Cancellation Related To Reverse Stock Split ShareCancellationRelatedToReverseStockSplit		usd
CY2024Q3	opgn	Conversion Of Preferred Stock Into Common Stock ConversionOfPreferredStockIntoCommonStock		usd
	us-gaap	Accretion Expense AccretionExpense		usd
	opgn	Cash Bonus Taken In Form Of Stock Compensation CashBonusTakenInFormOfStockCompensation		usd
	opgn	Gain On Impairment Adjustment GainOnImpairmentAdjustment		usd
	opgn	Gain On Settlement Of Compensation Expenses GainOnSettlementOfCompensationExpenses		usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount		usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
	opgn	Change In Fair Value Of Eib Loan ChangeInFairValueOfEibLoan		usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants		usd
	opgn	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts		usd
	opgn	Proceeds From Shortterm Insurance Financing ProceedsFromShorttermInsuranceFinancing		usd
	opgn	Payments On Shortterm Insurance Financing PaymentsOnShorttermInsuranceFinancing		usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		usd
	opgn	Rightofuse Assets Acquired Through Operating Leases RightofuseAssetsAcquiredThroughOperatingLeases		usd
	opgn	Purchased Equipment Not Yet Paid For PurchasedEquipmentNotYetPaidFor		usd
	opgn	Settlement Of Deferred Compensation And Severance SettlementOfDeferredCompensationAndSeverance		usd
	opgn	Issuance Of Common Stock Upon Conversion Of Preferred Stock IssuanceOfCommonStockUponConversionOfPreferredStock		usd
CY2024Q3	us-gaap	Inventory Net InventoryNet		usd
CY2023Q4	us-gaap	Inventory Net InventoryNet		usd
CY2024Q3	us-gaap	Revenues Revenues		usd
CY2024Q3	us-gaap	Revenues Revenues		usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
CY2024Q3	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount		usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2024Q3	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue		usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt		usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt		usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2024Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent		pure
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
	opgn	Operating Leases OperatingLeases		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10068111	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1633166	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24401	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1559786	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	3217353	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1117245	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	138	usd
CY2024Q3	opgn	Indemnification Assets IndemnificationAssets	832966	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	302262	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	302262	usd
CY2024Q3	us-gaap	Assets Assets	5469826	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	103868	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	49146	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	127601	usd
CY2024Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	89173	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	25926	usd
CY2024Q3	opgn	Shortterm Insurance Financing ShorttermInsuranceFinancing	180555	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	280	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	167021	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	589763	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1893794	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2021616	usd
CY2024Q3	us-gaap	Liabilities Liabilities	2483557	usd
CY2023Q4	us-gaap	Liabilities Liabilities	13443858	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10068111	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10068111	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1282686	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1282686	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	100681	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	12827	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	300736192	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	293991529	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-297850606	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-305493302	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-75138	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	2986269	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-11561584	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5469826	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1882274	usd
CY2023Q3	us-gaap	Revenues Revenues	699022	usd
	us-gaap	Revenues Revenues	196149	usd
	us-gaap	Revenues Revenues	2348601	usd
CY2023Q3	opgn	Cost Of Products Sold CostOfProductsSold	618796	usd
	opgn	Cost Of Products Sold CostOfProductsSold	31636	usd
	opgn	Cost Of Products Sold CostOfProductsSold	1925566	usd
CY2023Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	73174	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1575	usd
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	405582	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	488	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1201865	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	49308	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4403488	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	768551	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2034628	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4021321	usd
CY2024Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14846	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2522471	usd
CY2024Q3	us-gaap	Costs And Expenses CostsAndExpenses	783885	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	4264647	usd
	us-gaap	Costs And Expenses CostsAndExpenses	4272659	usd
	us-gaap	Costs And Expenses CostsAndExpenses	16140695	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-783885	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3565625	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4076510	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13792094	usd
CY2024Q3	opgn	Interest And Other Income Net InterestAndOtherIncomeNet	92131	usd
CY2023Q3	opgn	Interest And Other Income Net InterestAndOtherIncomeNet	24977	usd
	opgn	Interest And Other Income Net InterestAndOtherIncomeNet	242799	usd
	opgn	Interest And Other Income Net InterestAndOtherIncomeNet	86301	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	3238	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	396768	usd
	us-gaap	Interest Expense InterestExpense	4317	usd
	us-gaap	Interest Expense InterestExpense	1698564	usd
	opgn	Gain On Impairment Adjustment GainOnImpairmentAdjustment	2079575	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	9738487	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	9738487	usd
CY2024Q3	opgn	Gain On Settlement Of Compensation Expenses GainOnSettlementOfCompensationExpenses	570785	usd
	opgn	Gain On Settlement Of Compensation Expenses GainOnSettlementOfCompensationExpenses	570785	usd
CY2024Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-135930	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-288326	usd
CY2023Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	10389	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	65800	usd
CY2024Q3	opgn	Change In Fair Value Of Eib Loan Guaranty ChangeInFairValueOfEibLoanGuaranty	683200	usd
	opgn	Change In Fair Value Of Eib Loan Guaranty ChangeInFairValueOfEibLoanGuaranty	908586	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9714963	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1834789	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15626883	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15626883	usd
CY2024Q3	opgn	Net Income Loss Allocated To Preferred Stockholders Basic NetIncomeLossAllocatedToPreferredStockholdersBasic	-690467	usd
	opgn	Net Income Loss Allocated To Preferred Stockholders Basic NetIncomeLossAllocatedToPreferredStockholdersBasic	-519161	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8240611	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4062957	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7123535	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15626883	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	8931078	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4062957	usd
	us-gaap	Net Income Loss NetIncomeLoss	7642696	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15626883	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8931078	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4062957	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	7642696	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-15626883	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.43
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.63
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.51
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-23.80
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.35
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.63
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-23.80
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5760214	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	877815	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2837744	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	656585	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6603804	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	877815	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3571505	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	656585	shares
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	8931078	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4062957	usd
	us-gaap	Net Income Loss NetIncomeLoss	7642696	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15626883	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	78815	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	118178	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8931078	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3984142	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7642696	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15508705	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7575548	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	211122	usd
CY2023Q1	opgn	Offering Of Common Stock And Warrants Net Of Issuance Costs OfferingOfCommonStockAndWarrantsNetOfIssuanceCosts	6974050	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	153067	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-5736603	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	9177184	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	156529	usd
CY2023Q2	opgn	Cash Bonus Taken In Form Of Stocks Compensation CashBonusTakenInFormOfStocksCompensation	283554	usd
CY2023Q2	opgn	Offering Of Common Stock And Warrants Net Of Issuance Costs OfferingOfCommonStockAndWarrantsNetOfIssuanceCosts	3183650	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-113704	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-5827323	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	6859890	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-229483	usd
CY2023Q3	opgn	Offering Of Common Stock And Warrants Net Of Issuance Costs OfferingOfCommonStockAndWarrantsNetOfIssuanceCosts	30458	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	78815	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-4062957	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	2676723	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-11561584	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	188237	usd
CY2024Q1	opgn	Offering Of Preferred Stock And Warrants Net Of Issuance Costs OfferingOfPreferredStockAndWarrantsNetOfIssuanceCosts	200000	usd
CY2024Q1	opgn	Elimination Of Translation Adjustments Of Previously Dissolved Subsidiaries EliminationOfTranslationAdjustmentsOfPreviouslyDissolvedSubsidiaries	75138	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	287967	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-10810242	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	368391	usd
CY2024Q2	opgn	Offering Of Preferred Stock And Warrants Net Of Issuance Costs OfferingOfPreferredStockAndWarrantsNetOfIssuanceCosts	350000	usd
CY2024Q2	us-gaap	Profit Loss ProfitLoss	-1576349	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-11668200	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1530	usd
CY2024Q3	opgn	Cash Compensation Taken In Form Of Stock Compensation CashCompensationTakenInFormOfStockCompensation	1333285	usd
CY2024Q3	opgn	Offering Of Preferred Stock And Warrants Net Of Issuance Costs OfferingOfPreferredStockAndWarrantsNetOfIssuanceCosts	2400217	usd
CY2024Q3	opgn	Issuance Of Common Stock Pursuant To Equity Line Of Credit IssuanceOfCommonStockPursuantToEquityLineOfCredit	1988359	usd
CY2024Q3	us-gaap	Profit Loss ProfitLoss	8931078	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	2986269	usd
	us-gaap	Net Income Loss NetIncomeLoss	7642696	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15626883	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	129502	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1070581	usd
	us-gaap	Accretion Expense AccretionExpense	1261495	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	558158	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	138168	usd
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	-54830	usd
	us-gaap	Inventory Lifo Reserve Period Charge InventoryLIFOReservePeriodCharge	535755	usd
	opgn	Cash Bonus Taken In Form Of Stock Compensation CashBonusTakenInFormOfStockCompensation	283554	usd
	opgn	Gain On Impairment Adjustment GainOnImpairmentAdjustment	2079575	usd
	opgn	Gain On Settlement Of Compensation Expenses GainOnSettlementOfCompensationExpenses	570785	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-75138	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-65800	usd
	opgn	Change In Fair Value Of Eib Loan ChangeInFairValueOfEibLoan	-10873867	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-78915	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-91522	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-54830	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-290366	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-98233	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-86516	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-7281	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	399197	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	337284	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1161958	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-25926	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	54388	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4637508	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12643099	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	799498	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-799498	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10188158	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	2950217	usd
	opgn	Proceeds From Issuance Of Common Stock Net Of Issuance Costs ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts	1988359	usd
	opgn	Proceeds From Shortterm Insurance Financing ProceedsFromShorttermInsuranceFinancing	300926	usd
	opgn	Payments On Shortterm Insurance Financing PaymentsOnShorttermInsuranceFinancing	120371	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	3910010	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	280	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2523	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5118851	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6275625	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15977	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	481343	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7150995	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1454085	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7935659	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1935428	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	784664	usd
	us-gaap	Interest Paid Net InterestPaidNet	4317	usd
	us-gaap	Interest Paid Net InterestPaidNet	1422343	usd
	opgn	Rightofuse Assets Acquired Through Operating Leases RightofuseAssetsAcquiredThroughOperatingLeases	801321	usd
	opgn	Purchased Equipment Not Yet Paid For PurchasedEquipmentNotYetPaidFor	94784	usd
	opgn	Settlement Of Deferred Compensation And Severance SettlementOfDeferredCompensationAndSeverance	1333285	usd
	opgn	Issuance Of Common Stock Upon Conversion Of Preferred Stock IssuanceOfCommonStockUponConversionOfPreferredStock	2950217	usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	13300000	usd
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	5000000.0	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1633166	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2500000	usd
	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	2500	usd
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2500	usd
	opgn	Accumulated Other Comprehensive Loss AccumulatedOtherComprehensiveLoss	-75100	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-75138	usd
	opgn	Incremental Loss IncrementalLoss	100000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_z0rb91hkItv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_z9O1kC98oIlg">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the accompanying unaudited condensed consolidated financial statements, estimates are used for, but not limited to, liquidity assumptions, revenue recognition, stock-based compensation, allowances for doubtful accounts and inventory obsolescence, property and equipment, lease right-of-use assets, discount rates used to discount unpaid lease payments to present values, valuation of derivative financial instruments measured at fair value on a recurring basis, and deferred tax assets and liabilities and related valuation allowance. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	302262	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	302262	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1633166	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1151823	usd
CY2024Q3	us-gaap	Restricted Cash RestrictedCash	302262	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	302262	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1935428	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1454085	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2024Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1225975	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1280805	usd
CY2024Q3	us-gaap	Inventory Gross InventoryGross	1225975	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	1280805	usd
CY2024Q3	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	-1225975	usd
CY2023Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	-1280805	usd
CY2024Q3	us-gaap	Other Inventory OtherInventory	1225975	usd
CY2023Q4	us-gaap	Other Inventory OtherInventory	1280805	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	187255	usd
CY2023Q3	opgn	Research And Development Expense From Government Grant ResearchAndDevelopmentExpenseFromGovernmentGrant	78752	usd
	opgn	Research And Development Expense From Government Grant ResearchAndDevelopmentExpenseFromGovernmentGrant	301229	usd
CY2024Q3	us-gaap	Grants Receivable GrantsReceivable	0	usd
	opgn	Tax Benefit Percentage TaxBenefitPercentage	0.50	pure
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	241110447	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	232682072	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	8931078	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4062957	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	8931078	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-4062957	usd
CY2024Q3	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	-690467	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8240611	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4062957	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8931078	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4062957	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5760214	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	877815	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5760214	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	877815	shares
CY2024Q3	us-gaap	Amount Of Dilutive Securities Esop Convertible Preferred Stock AmountOfDilutiveSecuritiesESOPConvertiblePreferredStock	843590	usd
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6603804	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	877815	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.43
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.63
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.35
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.63
	us-gaap	Net Income Loss NetIncomeLoss	7642696	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15626883	usd
	us-gaap	Net Income Loss NetIncomeLoss	7642696	usd
	us-gaap	Net Income Loss NetIncomeLoss	-15626883	usd
	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	-519161	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7123535	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15626883	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	7642696	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-15626883	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2837744	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	656585	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2837744	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	656585	shares
	us-gaap	Amount Of Dilutive Securities Esop Convertible Preferred Stock AmountOfDilutiveSecuritiesESOPConvertiblePreferredStock	733761	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3571505	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	656585	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.51
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-23.80
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-23.80
	us-gaap	Weighted Average Limited Partnership Units Outstanding Diluted WeightedAverageLimitedPartnershipUnitsOutstandingDiluted	1200000	shares
	us-gaap	Weighted Average Limited Partnership Units Outstanding Diluted WeightedAverageLimitedPartnershipUnitsOutstandingDiluted	1100000	shares
CY2023Q3	us-gaap	Revenues Revenues	699022	usd
	us-gaap	Revenues Revenues	196149	usd
	us-gaap	Revenues Revenues	2348601	usd
CY2023Q3	us-gaap	Revenues Revenues	699022	usd
	us-gaap	Revenues Revenues	196149	usd
	us-gaap	Revenues Revenues	2348601	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	142061	usd
CY2023	us-gaap	Contract With Customer Asset Purchase ContractWithCustomerAssetPurchase	74109	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-144196	usd
CY2023	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-46048	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25926	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-21096	usd
	opgn	Refunded To Customers In Current Period RefundedToCustomersInCurrentPeriod	-4830	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	10873867	usd
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	10873867	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	10873867	usd
CY2017Q2	us-gaap	Accounts Payable Interest Bearing Interest Rate AccountsPayableInterestBearingInterestRate	0.04	pure
CY2019Q2	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	5000000.0
CY2019Q2	us-gaap	Line Of Credit Facility Increase Decrease For Period Net LineOfCreditFacilityIncreaseDecreaseForPeriodNet	5000000.0
CY2022Q2	us-gaap	Payments For Loans PaymentsForLoans	700000
CY2023Q2	opgn	Aggrement Amount Paid AggrementAmountPaid	1000000
CY2024Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	3238	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	396768	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	4317	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	1698564	usd
CY2024Q2	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	300926	usd
CY2024Q2	us-gaap	Payments For Loans PaymentsForLoans	31172	usd
CY2024Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0775	pure
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10068111	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10068111	shares
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	6999000	shares
CY2024Q3	opgn	Preferred Stock Share Undesignated PreferredStockShareUndesignated	6999000	shares
CY2023Q1	opgn	Exercise Price Of Common Warrants ExercisePriceOfCommonWarrants	26.50
CY2023Q1	opgn	Exercise Price Of Pre Funded Warrants ExercisePriceOfPreFundedWarrants	0.10
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.785
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	60500	shares
CY2023Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023Q2	opgn	Prefunded Warrants In Shares PrefundedWarrantsInShares	389083	shares
CY2023Q2	opgn	Common Warrants Issued CommonWarrantsIssued	449583	shares
CY2023Q2	opgn	Price Per Share Of Common Stock And Accompanying Common Warrant PricePerShareOfCommonStockAndAccompanyingCommonWarrant	7.785
CY2023Q2	opgn	Price Per Share Of Prefunded Warrant And Common Warrant PricePerShareOfPrefundedWarrantAndCommonWarrant	7.685
CY2023Q2	opgn	Gross Proceeds From Equity Transaction GrossProceedsFromEquityTransaction	3500000	usd
CY2023Q2	opgn	Net Proceeds From Issuance Of Common Stock NetProceedsFromIssuanceOfCommonStock	3000000.0	usd
CY2023Q2	opgn	Exercise Price Of Common Warrants ExercisePriceOfCommonWarrants	7.785
CY2023Q2	opgn	Number Of Repriced Warrants To Purchase Shares NumberOfRepricedWarrantsToPurchaseShares	639691	shares
CY2024Q2	opgn	Additional Paid Capital AdditionalPaidCapital	300000	usd
CY2023Q4	opgn	Number Of Warrants Exercised In Shares NumberOfWarrantsExercisedInShares	200000	shares
CY2023Q4	opgn	Gross Proceeds For Warrant Inducement GrossProceedsForWarrantInducement	2057000.000	usd
CY2023Q4	opgn	Shares Of Series D Preferred Stock For Sale SharesOfSeriesDPreferredStockForSale	1000
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.01
CY2023Q4	us-gaap	Share Price SharePrice	4.09
CY2023Q4	opgn	Affiliates Holding Percentage AffiliatesHoldingPercentage	0.1999	pure
CY2023Q4	opgn	Warrants Available For Inducement In Shares WarrantsAvailableForInducementInShares	1089274	shares
CY2023Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	7.785
CY2023Q4	opgn	Additional Consideration Required Per Share AdditionalConsiderationRequiredPerShare	0.25
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	1	pure
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	3000000.0	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1530	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	-229483	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	558158	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	138168	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	5813	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	8594	shares
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	4163	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1095517	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	1095517	shares
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	832966	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	138	usd
CY2024Q3	opgn	Lease Right Of Use Asset LeaseRightOfUseAsset	832966	usd
CY2023Q4	opgn	Lease Right Of Use Asset LeaseRightOfUseAsset	138	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	167021	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	147943	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	280	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1893794	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2021616	usd
CY2024Q3	opgn	Lease Liability LeaseLiability	2060815	usd
CY2023Q4	opgn	Lease Liability LeaseLiability	2169839	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	90395	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	368179	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	378279	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	388682	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	399388	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1338299	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2963222	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	902407	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2060815	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	58496	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	176090	usd
	us-gaap	Lease Cost LeaseCost	175626	usd
	us-gaap	Lease Cost LeaseCost	487060	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y4M24D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.100	pure
	us-gaap	Operating Lease Payments OperatingLeasePayments	175488	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	484546	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	280	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2523	usd
	opgn	Operating Leases OperatingLeases	801321	usd
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001829126-24-007586-index-headers.html	Edgar Link	pending
0001829126-24-007586-index.html	Edgar Link	pending
0001829126-24-007586.txt	Edgar Link	pending
0001829126-24-007586-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
opgeninc_10q.htm	Edgar Link	pending
opgeninc_ex31-1.htm	Edgar Link	pending
opgeninc_ex31-2.htm	Edgar Link	pending
opgeninc_ex32-1.htm	Edgar Link	pending
opgn-20240930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
opgn-20240930_def.xml	Edgar Link	unprocessable
opgn-20240930_lab.xml	Edgar Link	unprocessable
opgn-20240930_pre.xml	Edgar Link	unprocessable
opgeninc_10q_htm.xml	Edgar Link	completed
opgn-20240930_cal.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPGN
OPGEN INC Stock $opgn

2024 Q4 Form 10-Q Financial Statement

#000182912624007586 Filed on November 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPGN OPGEN INC Stock $opgn

2024 Q4 Form 10-Q Financial Statement

#000182912624007586 Filed on November 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPGN
OPGEN INC Stock $opgn